Patient Switching Behaviors Impact on Adherence and Engagement: A Predictive Analytics and Machine Learning Approach to Improving Hub Performance and Patient Outcomes Today we have access to more data, from more sources than we could ever…
An emerging clinical stage biotech contracted with EVERSANA to conduct Phase II trial enrollment support for an ultra-rare liver disease through our Seeker Health platform. Because of the ultra-rare patient population and nature of the therapy,…
EVERSANA is uniquely positioned to follow the trends and introduce new models and strategies to maximize the value of pharmaceutical products through Digital Medicine Solutions and Execution. Digital Solutions can be deployed to impact the entire…
Facebook for Business states that, “Augmented reality (AR) and virtual reality (VR) are the future.” The problem is that we have been saying this for years. How can a technology that has been around for more…
As the patient point of care continues to change and evolve, EVERSANA has identified challenges facing how we interact with patients, and how these challenges will impact patient engagement now and in the future. Supporting patients…
One could make the argument that there are four situational categories under which all health systems now fall on the journey toward more value-based care and away from the fee-for-service model. Assisting health systems in successfully…
The Digital Therapeutics market continues to evolve at a rapid pace. In this podcast, hosted by Erica Sosnowski, host of the podcast series “The Platform”, we discuss current trends in the life sciences industry and the…
Patient Switching Behaviors Impact on Adherence and Engagement: A Predictive Analytics and Machine Learning Approach to Improving Hub Performance and Patient Outcomes Today we have access to more data, from more sources than we could ever…
By definition, leaders must have followers, who are defined as people who must be shown the way. While this is within most leaders’ grasps when the road ahead is straight and wide and the destination is…
The Institute for Clinical and Economic Review (ICER) has been very responsive to the current public health pandemic, from adjusting their review timelines to assessing COVID-19 impact on drug pricing and patient access. Within a few…
Good news, this month’s issue of the Pricentric Newsletter is now available for download. Fill out the form below to download the Newsletter!
